Inloggad som:

avslutad_NMDSG14A

Är du som patient intresserad av mer information om en studie, kontakta din behandlande läkare.
avslutad_NMDSG14A
MDSG14A. A phase I/II, Open-Label, Multicenter Study of the Safety, Efficacy and Immune Response of Histamine Dihydrochloride and Low-dose Interleukin-2 in Chronic Myelomonocytic Leukemia (CMML)
NMDSG14A. A phase I/II, Open-Label, Multicenter Study of the Safety, Efficacy and Immune Response of Histamine Dihydrochloride and Low-dose Interleukin-2 in Chronic Myelomonocytic Leukemia (CMML)
PLACEHOLDER
Mer information om studien för vårdgivare
Observation
Ej tillämpbar
Ej tillämpbar
Ej tillämpbar
https://clinicaltrials.gov/ct2/show/NCT03040401?term=A+phase+I%2FII%2C+Open-Label%2C+Multicenter+Study+of+the+Safety%2C+Efficacy+and+Immune+Response+of+Histamine+Dihydrochloride+and+Low-dose+Interleukin-2+in+Chronic+Myelomonocytic+Leukemia+%28CMML%29&cntry=SE&rank=1

Studien ändrades senast av: studysonia (2023-10-02)

Tillbaka till listan